Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Gastric Carcinoma”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Large-scale testing (Phase 3)Study completedNCT01516944
What this trial is testing

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Hebei Medical University 749
Testing effectiveness (Phase 2)Looking for participantsNCT05536102
What this trial is testing

The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)

Who this might be right for
Gastric Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 38
Large-scale testing (Phase 3)UnknownNCT01523015
What this trial is testing

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal Junction
Medical University of Lublin 100
Testing effectiveness (Phase 2)UnknownNCT01160419
What this trial is testing

Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer

Who this might be right for
Gastric Cancer
Ludwig-Maximilians - University of Munich 49
Testing effectiveness (Phase 2)Looking for participantsNCT07026149
What this trial is testing

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01542294
What this trial is testing

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177068
What this trial is testing

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Henan Cancer Hospital 42
Post-approval studies (Phase 4)UnknownNCT02380131
What this trial is testing

Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

Who this might be right for
HER-2 Positive Gastric CancerLiver Metastasis
Hebei Medical University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07315035
What this trial is testing

QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer

Who this might be right for
Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University 74
Not applicableLooking for participantsNCT06649474
What this trial is testing

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

Who this might be right for
Pancreatic CancerResectable Pancreatic AdenocarcinomaAdenocarcinoma+3 more
University Hospital, Clermont-Ferrand 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02931890
What this trial is testing

Multicentric Randomised Trial for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
The Netherlands Cancer Institute 207
Large-scale testing (Phase 3)Looking for participantsNCT06755554
What this trial is testing

Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer

Who this might be right for
Gastric Cancer Stage IIGastric Cancer Stage IIIGastric Cancer+1 more
Ukrainian Society of Clinical Oncology 105
Early research (Phase 1)Ended earlyNCT04931823
What this trial is testing

Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Conjupro Biotherapeutics, Inc. 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817826
What this trial is testing

TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.

Who this might be right for
Gastric CancerMicrosatellite Instability
Gruppo Oncologico del Nord-Ovest 31
Large-scale testing (Phase 3)Study completedNCT01515748
What this trial is testing

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Sanofi 530
Testing effectiveness (Phase 2)UnknownNCT00420394
What this trial is testing

Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer

Who this might be right for
Stomach Neoplasms
Soroka University Medical Center 30
Not applicableLooking for participantsNCT04047953
What this trial is testing

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Peking University Cancer Hospital & Institute 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063
What this trial is testing

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced
zhoujing 35
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04196465
What this trial is testing

Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers

Who this might be right for
Subjects With Resectable and Localized Gastric CancerSubjects With Resectable Esophageal Cancer or Liver CancerSubjects With Resectable Liver Cancer
Asan Medical Center 48
Load More Results